Get the Stockscreener App
8.50
0.47%
-0.04
Mimedx Group Inc Stock (MDXG) Latest News
Insiders At MiMedx Group Sold US$659k In Stock, Alluding To Potential Weakness - Simply Wall St
MIMEDX to Host Fourth Quarter and Full Year 2024 Operating and Financial Results Conference Call on February 26 - GlobeNewswire
MIMEDX Q4 2024 Earnings Call: Key Financial Results Coming February 26What to Watch - StockTitan
MiMedx Group, Inc. (NASDAQ:MDXG) Shares Sold by Chicago Capital LLC - MarketBeat
MiMedx Group, Inc. (NASDAQ:MDXG) Shares Purchased by SG Americas Securities LLC - MarketBeat
MiMedx Group (NASDAQ:MDXG) Shares Up 5.8%Time to Buy? - MarketBeat
MiMedx Group, Inc. (NASDAQ:MDXG) Receives $12.00 Consensus Price Target from Analysts - Defense World
MiMedx Group, Inc. to Host Earnings Call - ACCESS Newswire
(MDXG) Proactive Strategies - Stock Traders Daily
MiMedx Group, Inc. (NASDAQ:MDXG) Given Average Rating of "Buy" by Brokerages - MarketBeat
JPMorgan Chase & Co. Acquires 215,995 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
JPMorgan Chase & Co. Buys 215,995 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - MarketBeat
MiMedx Group, Inc.'s (NASDAQ:MDXG) one-year returns climbed after last week's 6.2% gain, institutional investors must be happy - Simply Wall St
Cantor Fitzgerald Predicts MiMedx Group FY2025 Earnings - MarketBeat
MiMedx Group Updates Investor Presentation in Recent 8-K Filing - Defense World
Learn to Evaluate (MDXG) using the Charts - Stock Traders Daily
Barclays PLC Buys 163,005 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
Barclays PLC Purchases 163,005 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - MarketBeat
Tendonitis Pipeline Insights 2024: Therapies, Clinical Trials, MOA, ROA, and Developments | MetrioPharm, MiMedX group, InGeneron, Novartis, R3 Stem Cell - Barchart
MiMedx Group, Inc.'s (NASDAQ:MDXG) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - Simply Wall St
Principal Financial Group Inc. Purchases 3,292 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
(MDXG) Trading Report - Stock Traders Daily
MiMedx Group, Inc. (NASDAQ:MDXG) Receives $12.00 Consensus Target Price from Analysts - Defense World
MiMedx Group, Inc. (NASDAQ:MDXG) Given Average Recommendation of "Buy" by Analysts - MarketBeat
MiMedx Group, Inc. (NASDAQ:MDXG) Shares Bought by Geode Capital Management LLC - Defense World
Northland Capmk Predicts MiMedx Group Q1 Earnings - MarketBeat
Northland Capmk Forecasts MiMedx Group Q1 Earnings - Defense World
MiMedx Group, Inc. (NASDAQ:MDXG) Shares Acquired by Barclays PLC - Defense World
Barclays PLC Has $1.55 Million Stake in MiMedx Group, Inc. (NASDAQ:MDXG) - MarketBeat
How the (MDXG) price action is used to our Advantage - Stock Traders Daily
Jane Street Group LLC Grows Position in MiMedx Group, Inc. (NASDAQ:MDXG) - MarketBeat
MiMedx Group, Inc. (NASDAQ:MDXG) Shares Acquired by Jane Street Group LLC - Defense World
We Think MiMedx Group (NASDAQ:MDXG) Can Manage Its Debt With Ease - Simply Wall St
State Street Corp Lowers Position in MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
State Street Corp Has $22.81 Million Stock Position in MiMedx Group, Inc. (NASDAQ:MDXG) - MarketBeat
MiMedx Group, Inc. (NASDAQ:MDXG) Shares Bought by Fmr LLC - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 33,241 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
MIMEDX Group's SWOT analysis: wound care firm's stock faces market headwinds - Investing.com
MIMEDX Files Patent Infringement Lawsuit Against Surgenex - GlobeNewswire
MiMedx Group (MDXG) Files Patent Infringement Lawsuit Against Surgenex - StreetInsider.com
MIMEDX Battles Patent Infringement: Files Major Lawsuit Over Placental Allograft Technology - StockTitan
MiMedx extends corporate HQ lease, ensures director indemnification - Investing.com
MiMedx extends corporate HQ lease, ensures director indemnification By Investing.com - Investing.com UK
The Manufacturers Life Insurance Company Raises Position in MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
(MDXG) On The My Stocks Page - Stock Traders Daily
EX-MiMEDX EMPLOYEES ALLEGE MiMEDX "PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE P - The Eastern Progress Online
MIMEDX Group's SWOT analysis: wound care firm's stock faces growth hurdles - Investing.com Nigeria
0.82%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):